PrimeRFP SCOUT · Federal Contract Recompete Brief

36C77021N0218Valbenazine 40mg ORAL CAP 30ct NDC — Neurocrine Biosciences, Inc

Public-record facts for this award are shown above. Open SCOUT for live scoring relative to your firm, watchlists, and capture workflow.

National Cmop Office (36C770)

Awarding office

Neurocrine Biosciences, Inc

Recipient

—

Estimated value

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Neurocrine Biosciences, Inc — $90

Contract facts

Federal

Contract number36C77021N0218

Also listed as36C770-21-N-0218

AgencyNational Cmop Office (36C770)

Awarding officeNational Cmop Office (36C770)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentNeurocrine Biosciences, Inc

UEIGMQSH4CZ7EC9

PSC6505

VALBENAZINE 40MG ORAL CAP 30CT NDC: 70370-2040-01 VALBENAZINE 80MG ORAL CAP 30CT NDC: 70370-1080-01) is a federal award for National Cmop Office (36C770) held by Neurocrine Biosciences, Inc. Estimated value —.

VALBENAZINE 40MG ORAL CAP 30CT NDC: 70370-2040-01 VALBENAZINE 80MG ORAL CAP 30CT NDC: 70370-1080-01)

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C77021N0218?

36C77021N0218 (Valbenazine 40mg ORAL CAP 30ct NDC) is a National Cmop Office (36C770) award with an estimated value of —, currently held by Neurocrine Biosciences, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C770-21-N-0218?

36C770-21-N-0218 is the dashed form of PIID 36C77021N0218 (Valbenazine 40mg ORAL CAP 30ct NDC), held by Neurocrine Biosciences, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C77021N0218?

National Cmop Office (36C770) awarded 36C77021N0218 to Neurocrine Biosciences, Inc.

Who is the incumbent on 36C77021N0218?

Neurocrine Biosciences, Inc is the incumbent.

When does Neurocrine Biosciences, Inc’s 36C77021N0218 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 36C77021N0218 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.